Company
Amber Therapeutics
We’re developing the first adaptive neuromodulation therapy that is able to treat women suffering with mixed urinary incontinence
Claim, correct or request removal
Record updated 28 September 2026
About
Amber Therapeutics was founded in 2021 by Aidan Crawley, Tim Denison, Stefan De Wachter and Charles Knowles with a mission to develop and deliver breakthrough neuromodulation therapies that can fundamentally transform outcomes in areas of unmet clinical need. Amber UI is the company’s first therapy, aiming to restore normal physiological function in women suffering with mixed urinary incontinence.
Products
- Picostim
- Amber UI
Loading relationship preview